The role of imaging in malignant pleural mesothelioma

Seminars in Oncology

Volumn 29, Issue 1, 2002, Pages 26-35

  Marom, Edith M ^a,b   Erasmus, Jeremy J ^a,b   Pass, Harvey I ^a,b   Patz Jr , Edward F ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; FLUORODEOXYGLUCOSE F 18; RADIOISOTOPE;

ADULT; AGED; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; FEMALE; GLUCOSE METABOLISM; HUMAN; LUNG METASTASIS; LUNG NODULE; LYMPH NODE METASTASIS; MALE; MALIGNANT MESOTHELIOMA; MEDIASTINUM LYMPH NODE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEURA EFFUSION; PLEURA MESOTHELIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY; TUMOR CELL;

EID: 0036182680     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2002.30228     Document Type: Article

References (54)

1. Current pathogenetic concepts of diffuse malignant mesothelioma
2. Analysis of current trends in United States mesothelioma incidence
3. Extensive pulmonary metastases in malignant pleural mesothelioma. A rare clinical and radiographic presentation
4. Miliary mesothelioma
5. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients
6. Aggressive multimodality therapy for malignant pleural mesothelioma
7. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma
8. Malignant mesothelioma in south east England: Clinicopathological experience of 272 cases
9. Diagnosis and prognostic factors in malignant pleural mesothelioma: A retrospective analysis of sixty-five patients
10. Prognostic factors of malignant mesothelioma of the pleura
11. Treatment and survival in diffuse malignant pleural mesothelioma: A study of 83 cases from the Massachusetts General Hospital
12. Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients
13. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B
14. Chemotherapy in malignant pleural mesothelioma. A review
15. Malignant pleural mesothelioma: A disease unaffected by current therapeutic maneuvers
16. The radiology of thoracic malignant mesothelioma
17. Radiological features of diffuse mesothelioma
18. The radiological manifestations of malignant pleural mesothelioma
19. Clinical presentation and natural history of benign and malignant mesothelioma
20. Mesothelioma: Current perspectives
21. Rib destruction: A neglected finding in malignant mesothelioma
22. Extrathoracic lymph node metastases in malignant pleural mesothelioma
23. Diffuse malignant mesothelioma presenting as bilateral malignant lymphangitis
24. Pleural plaques and risk for bronchial carcinoma and mesothelioma. A prospective study
25. From the archives of the AFIP. Malignant pleural mesothelioma: Radiologic-pathologic correlation
26. Pleural mesothelioma with calcified liver metastases
27. CT in differential diagnosis of diffuse pleural disease
28. Malignant pleural mesothelioma: CT manifestations in 50 cases
29. Malignant pleural mesothelioma: The spectrum of manifestations on CT in 70 cases
30. CT of malignant pleural mesothelioma
31. A comparative study of mesothelioma and asbestosis using computed tomography and conventional chest radiography
32. CT of malignant pleural mesothelioma
33. Malignant pleural mesothelioma: Value of CT and MR imaging in predicting resectability
34. The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma
35. The pathology of asbestos related disease
36. Staging of malignant pleural mesothelioma: Comparison of CT and MR imaging
37. Metabolic imaging of malignant pleural mesothelioma with fluorodcoxyglucose positron emission tomography
38. Nodular histiocytic/mesothelial hyperplasia: A lesion potentially mistaken for a neoplasm in transbronchial biopsy
39. Differentiation of serosal hyperplasia and neoplasia in biopsies
40. Malignant pleural mesothelioma: US-guided histologic core-needle biopsy
41. CT-guided pleural needle biopsy in the diagnosis of malignant mesothelioma
42. Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 1: Diagnosis
43. Surgery of mesothlioma of the pleura
44. The role of closed pleural needle biopsy in the diagnosis of malignant mesothelioma of the pleura
45. Malignant mesothelioma of the pleura
46. A proposed new international TNM staging system for malignant pleural mesothelioma
47. The proposed new international TNM staging system for malignant pleural mesothelioma: Application to imaging
48. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically
49. The importance of surgical staging in the treatment of malignant pleural mesothelioma
50. Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma
51. Imaging after thoracotomy
52. Chest wall reconstruction following resection of large primary malignant tumors
53. Diaphragm reconstruction with autologous fascia lata: Report of a case
54. Imaging of the expanded polytetrafluoroethylene prosthetic diaphragm following extrapleural pneumonectomy for mesothelioma